A significant advance in the molecular diagnosis of PVOD/PCH was the finding of biallelic variants in the gene encoding eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4) [8, 9]. This evidence concerns the gene EIF2AK4 and pulmonary venoocclusive disease.